Search

everythinglearnresearchcommunity

for

Search:↓

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

CTP-543 is generally safe for treating alopecia areata.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

The FDA rejected a testosterone drug again due to safety concerns.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Dutasteride may help reduce brain inflammation and improve cognition.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Intradermal dutasteride effectively and safely improves hair growth in early-stage androgenetic alopecia.

Tamoxifen caused hair loss in a 52-year-old woman.